StockData
Amgen Inc logo

Amgen Inc (AMGN) operating KPIs

AMGNNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026Score 17/3039% above fair value
$466.01+5.28 (+1.15%)

Close on Oct 30, 2026Market cap $251.94BP/E 28.9Yield 2.07%

Amgen goodwill Acquired During Period (legacy) ($M) ($M)

Form 10-K Goodwill and Other Intangible Assets Note (XBRL)

Latest, Q4 2018
0
Period ended Dec 31, 2018
Change on a year earlier
–
0 in Q4 2017
History
16 quarters
Since Q1 2015
Sources
9
Documents cited below

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedGoodwill Acquired During Period (legacy) ($M) ($M)Year on yearSource
Q4 2018Dec 31, 20180–Form 10-K (filed 2019-02-13) ↗
Q3 2018Sep 30, 20180–Form 10-Q (filed 2018-10-31) ↗
Q2 2018Jun 30, 20180–Form 10-Q (filed 2018-07-27) ↗
Q1 2018Mar 31, 20186–Form 10-Q (filed 2018-04-25) ↗
Q4 2017Dec 31, 20170-100.0%Form 10-K (filed 2018-02-13) ↗
Q3 2017Sep 30, 20170–10-Q FY2017 (XBRL) ↗
Q2 2017Jun 30, 20170–10-Q FY2017 (XBRL) ↗
Q1 2017Mar 31, 20170-100.0%10-Q FY2017 (XBRL) ↗
Q4 2016Dec 31, 2016-2-101.9%Form 10-K (filed 2019-02-13) ↗
Q3 2016Sep 30, 20160–10-Q FY2016 (XBRL) ↗
Q2 2016Jun 30, 20160–10-Q FY2016 (XBRL) ↗
Q1 2016Mar 31, 20162–10-Q FY2016 (XBRL) ↗
Q4 2015Dec 31, 2015108–Form 10-K (filed 2017-02-14) ↗
Q3 2015Sep 30, 20150–10-Q FY2015 (XBRL) ↗
Q2 2015Jun 30, 20150–10-Q FY2015 (XBRL) ↗
Q1 2015Mar 31, 20150–10-Q FY2015 (XBRL) ↗

Cite this data

StockData. (2026). Amgen Goodwill Acquired During Period (legacy) ($M) ($M), quarterly Q1 2015–Q4 2018 [Data set]. Compiled from Amgen SEC filings and investor materials. https://stockdatahq.com/stocks/amgn/kpis/goodwill_acq

See every metric in the Amgen KPI table. Data updated Oct 28, 2026.